Hyogo, Japan

Hiromu Matsumura


Average Co-Inventor Count = 3.7

ph-index = 5

Forward Citations = 96(Granted Patents)


Location History:

  • Ashiya, JP (1980 - 1994)
  • Hyogo, JP (1987 - 1995)

Company Filing History:


Years Active: 1980-1995

Loading Chart...
17 patents (USPTO):Explore Patents

Title: Hiromu Matsumura: Innovator in Tetrahydropyridine Derivatives

Introduction

Hiromu Matsumura is a prominent inventor based in Hyogo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his work on tetrahydropyridine derivatives. With a total of 17 patents to his name, Matsumura's innovations are recognized for their potential therapeutic applications.

Latest Patents

Matsumura's latest patents focus on tetrahydropyridine derivatives, which are compounds that exhibit high affinity and specificity to sigma receptors. These compounds are believed to be effective in treating certain psychoses. One of his notable patents describes a compound of a specific formula, where n is an integer ranging from 2 to 6, and p and q are integers of 0 or 1, with certain exclusions. This compound, along with its pharmaceutically acceptable acid addition salts, shows promise in the treatment of psychoses due to its high affinity for sigma receptors.

Career Highlights

Throughout his career, Matsumura has worked with reputable companies, including Shionogi & Company Limited and Shionogi & Co., Ltd. His work has significantly advanced the understanding and development of pharmaceutical compounds.

Collaborations

Matsumura has collaborated with notable colleagues in his field, including Toshisada Yano and Akira Matsushita. Their combined expertise has contributed to the success of various projects and innovations.

Conclusion

Hiromu Matsumura's contributions to the field of pharmaceuticals, particularly through his work on tetrahydropyridine derivatives, highlight his role as a key innovator. His patents reflect a commitment to advancing medical science and improving treatment options for psychoses.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…